skip to main content

H.R. 3 (110th): Stem Cell Research Enhancement Act of 2007

The text of the bill below is as of Jan 5, 2007 (Introduced).



1st Session

H. R. 3


January 5, 2007

(for herself, Mr. Castle, Mr. Langevin, Mr. Shays, Mr. Mitchell, Mr. Kirk, Mr. Dingell, Mr. Dent, Mr. Rangel, Mr. Porter, Mr. Waxman, Mr. Lewis of California, Mr. Conyers, Mr. Regula, Mr. Pallone, Mrs. Bono, Mr. Stark, Mr. Bilbray, Ms. Baldwin, Mr. Tom Davis of Virginia, Mrs. Capps, Mr. Reichert, Mr. Carnahan, Mr. Ramstad, Mr. Lewis of Georgia, Mrs. Biggert, Mr. Perlmutter, Mr. Gilchrest, Mr. Abercrombie, Mr. Ackerman, Mr. Allen, Mr. Altmire, Mr. Andrews, Mr. Arcuri, Mr. Baca, Mr. Baird, Ms. Bean, Mr. Becerra, Ms. Berkley, Mr. Berman, Mr. Berry, Mr. Bishop of New York, Mr. Blumenauer, Ms. Bordallo, Mr. Boswell, Mr. Boucher, Mr. Boyd of Florida, Mr. Brady of Pennsylvania, Mr. Braley of Iowa, Ms. Corrine Brown of Florida, Mr. Butterfield, Mr. Capuano, Mr. Cardoza, Ms. Carson, Ms. Castor, Mr. Chandler, Mrs. Christensen, Mr. Clay, Mr. Cleaver, Mr. Clyburn, Mr. Cohen, Mr. Cooper, Mr. Costa, Mr. Courtney, Mr. Crowley, Mr. Cuellar, Mr. Cummings, Mr. Davis of Alabama, Mr. Davis of Illinois, Mrs. Davis of California, Mr. DeFazio, Mr. Delahunt, Ms. DeLauro, Mr. Dicks, Mr. Doggett, Mr. Ellison, Mr. Engel, Ms. Eshoo, Mr. Etheridge, Mr. Faleomavaega, Mr. Farr, Mr. Fattah, Mr. Filner, Mr. Frank of Massachusetts, Ms. Giffords, Mrs. Gillibrand, Mr. Gordon of Tennessee, Mr. Al Green of Texas, Mr. Gene Green of Texas, Mr. Grijalva, Mr. Gutierrez, Mr. Hall of New York, Mr. Hare, Ms. Harman, Mr. Hastings of Florida, Ms. Herseth, Mr. Higgins, Mr. Hinchey, Ms. Hirono, Mr. Hodes, Mr. Holt, Mr. Honda, Ms. Hooley, Mr. Hoyer, Mr. Inslee, Mr. Israel, Ms. Jackson-Lee of Texas, Mr. Jackson of Illinois, Mr. Jefferson, Ms. Eddie Bernice Johnson of Texas, Mr. Johnson of Georgia, Mrs. Jones of Ohio, Mr. Kagen, Mr. Kind, Mr. Klein of Florida, Mr. Kucinich, Mr. Lantos, Mr. Larsen of Washington, Mr. Larson of Connecticut, Ms. Lee, Mr. Levin, Mr. Loebsack, Ms. Zoe Lofgren of California, Mrs. Lowey, Mr. Lynch, Mr. Mahoney of Florida, Mrs. Maloney of New York, Mr. Markey, Mr. Matheson, Ms. Matsui, Ms. McCollum of Minnesota, Mr. McDermott, Mr. McGovern, Mr. McNerney, Mr. McNulty, Mr. Meehan, Mr. Meek of Florida, Mr. Michaud, Ms. Millender-McDonald, Mr. George Miller of California, Mr. Moore of Kansas, Ms. Moore of Wisconsin, Mr. Moran of Virginia, Mr. Murphy of Connecticut, Mr. Christopher Murphy of Pennsylvania, Mr. Nadler, Mrs. Napolitano, Ms. Norton, Mr. Obey, Mr. Olver, Mr. Ortiz, Mr. Pascrell, Mr. Pastor, Mr. Payne, Mr. Pomeroy, Mr. Price of North Carolina, Mr. Reyes, Mr. Rodriguez, Mr. Ross, Mr. Rothman, Ms. Roybal-Allard, Mr. Ruppersberger, Mr. Rush, Mr. Ryan of Ohio, Mr. Salazar, Ms. Linda T. Sánchez of California, Ms. Loretta Sanchez of California, Mr. Sarbanes, Ms. Schakowsky, Mr. Schiff, Mr. Scott of Georgia, Mr. Serrano, Mr. Sestak, Ms. Shea-Porter, Mr. Sherman, Mr. Sires, Mr. Skelton, Ms. Slaughter, Mr. Smith of Washington, Mr. Snyder, Ms. Solis, Mr. Space, Mr. Spratt, Ms. Sutton, Mrs. Tauscher, Mr. Thompson of Mississippi, Mr. Thompson of California, Mr. Tierney, Mr. Towns, Mr. Udall of Colorado, Mr. Udall of New Mexico, Mr. Upton, Mr. Van Hollen, Ms. Velázquez, Mr. Visclosky, Mr. Walz of Minnesota, Ms. Wasserman Schultz, Ms. Waters, Ms. Watson, Mr. Weiner, Mr. Welch of Vermont, Mr. Wexler, Ms. Woolsey, Mr. Wu, Mr. Wynn, Mr. Yarmuth, and Mr. Hinojosa) introduced the following bill; which was referred to the Committee on Energy and Commerce


To amend the Public Health Service Act to provide for human embryonic stem cell research.


Short title

This Act may be cited as the Stem Cell Research Enhancement Act of 2007.


Human embryonic stem cell research

Part H of title IV of the Public Health Service Act (42 U.S.C. 289 et seq.) is amended by inserting after section 498C the following:


Human embryonic stem cell research


In General

Notwithstanding any other provision of law (including any regulation or guidance), the Secretary shall conduct and support research that utilizes human embryonic stem cells in accordance with this section (regardless of the date on which the stem cells were derived from a human embryo) .


Ethical Requirements

Human embryonic stem cells shall be eligible for use in any research conducted or supported by the Secretary if the cells meet each of the following:


The stem cells were derived from human embryos that have been donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the clinical need of the individuals seeking such treatment.


Prior to the consideration of embryo donation and through consultation with the individuals seeking fertility treatment, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded.


The individuals seeking fertility treatment donated the embryos with written informed consent and without receiving any financial or other inducements to make the donation.



Not later than 60 days after the date of the enactment of this section, the Secretary, in consultation with the Director of NIH, shall issue final guidelines to carry out this section.


Reporting Requirements

The Secretary shall annually prepare and submit to the appropriate committees of the Congress a report describing the activities carried out under this section during the preceding fiscal year, and including a description of whether and to what extent research under subsection (a) has been conducted in accordance with this section.